Discover

LGND
Ligand Pharmaceuticals Incorporated
305.47
1 x 305.74
1 x 308.56
bid
ask
+
0.00
0.00%
09:30 AM
timesize
Ytd61.56%
1y130.61%
305.01
day range
311.25
129.55
52 week range
326.63
Open305.01Prev Close305.47Low305.01High311.25Mkt Cap6.12B
Vol2.54KAvg Vol341.64KEPS8.34P/E36.63Forward P/E34.01
Beta1.10Short Ratio4.25Inst. Own107.20%DividendN/ADiv YieldN/A
Ex Div Date07-02Earning08-0650-d Avg263.66200-d Avg215.631yr Est311.30

LGND News

benzinga.com
Citigroup Reinstates Buy on Ligand Pharmaceuticals, Announces $387 Price Target

Citigroup analyst Yigal Nochomovitz reinstates Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy an

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More
247wallst.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gil

Wall Street analysts are making bold moves on Tuesday, shaking up ratings for some of the biggest na

benzinga.com
RBC Capital Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $340

RBC Capital analyst Douglas Miehm maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperfor

Why Is Agenus Stock Falling on Tuesday?
benzinga.com
Why Is Agenus Stock Falling on Tuesday?

Agenus Inc. (AGEN) stock experiences profit-taking on Tuesday after a 111% surge. Discover the lates

Why Is Agenus Stock Gaining Monday?
benzinga.com
Why Is Agenus Stock Gaining Monday?

Agenus ($AGEN) stock rockets over 111% following stellar 3-year colorectal cancer data and a $340M f

benzinga.com
B of A Securities Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $388

B of A Securities analyst Jason Zemansky maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Bu

benzinga.com
Stifel Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $332

Stifel analyst Annabel Samimy maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and raise

benzinga.com
Ligand Plans $550M Convertible Notes Offering, To Use Notes Sale for Share Buybacks and Corporate Ne

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) ("Ligand") announced today its intention t

7 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
7 Health Care Stocks With Whale Alerts In Today's Session

benzinga.com
RBC Capital Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $262

RBC Capital analyst Douglas Miehm maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperfor

benzinga.com
Ligand Pharmaceuticals Affirms FY2026 Adj EPS Guidance of $8.50-$9.50 vs $9.13 Est; Affirms FY2026 S

Ligand Pharmaceuticals (NASDAQ:LGND) affirms FY2026 Adj EPS guidance from $8.50-$9.50 to $8.50-$9.50

benzinga.com
Ligand Pharmaceuticals Q1 Adj. EPS $1.63 Misses $1.82 Estimate, Sales $51.722M Miss $58.696M Estimat

Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $1.63 per share which missed the

benzinga.com
Orchestra BioMed Receives $15M Payment From Ligand Pharma Under Previously Disclosed Revenue Partici

$15 million payment fulfills previously scheduled tranche under royalty-based financing agreement, b

benzinga.com
HC Wainwright & Co. Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $289

HC Wainwright & Co. analyst Joseph Pantginis maintains Ligand Pharmaceuticals (NASDAQ:LGND) w

benzinga.com
RBC Capital Maintains Outperform on Ligand Pharmaceuticals, Raises Price Target to $252

RBC Capital analyst Douglas Miehm maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperfor

Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million
benzinga.com
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million

Ligand to acquire XOMA Royalty for $739 million, raising 2026 outlook as analysts maintain Buy ratin

XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday
benzinga.com
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday

U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acq

benzinga.com
Ligand Pharmaceuticals To Acquire XOMA Royalty For $39.00 Per Share In Cash, Ligand Raises FY2026 Ad

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and XOMA Royalty Corporation ("XOMA Royalty&#3

benzinga.com
Citigroup Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $282

Citigroup analyst Yigal Nochomovitz maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy and

benzinga.com
HC Wainwright & Co. Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $243

HC Wainwright & Co. analyst Joseph Pantginis maintains Ligand Pharmaceuticals (NASDAQ:LGND) w

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
benzinga.com
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations Fo

Top Wall Street analysts changed outlook on top names. For all analyst rating changes, see analyst r

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For February 27, 2025